-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622.P1.81 622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster I

Non-Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Zohra Nooruddin, MD1, William Robinson, MD, PhD1*, Daniel Pollyea, MD, MS2, Jonathan A Gutman, MD1, Clayton Smith, MD, FRCPC3, Zenggang Pan, MD3*, Craig T Jordan, PhD3*, Rachel Rabinovitch, MD4, Jeffrey Schowinsky4*, Xian Lu, PhD3*, Douglas Ney, MD1* and Manali Kamdar, MD1

1University of Colorado, Denver, CO
2Division of Hematology, University of Colorado School of Medicine, Aurora, CO
3Univeristy of Colorado, Denver, CO
4Univeristy of Colorado, Denver

Roberto Castelli, Prof1*, Davide Rossi, MD, PhD2, Arquati Massimo1*, Suffritti Chiara1*, Andrea Zanichelli1*, Wu Maddalena1* and Cicardi Marco, Prof1*

1Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy., Milan, Italy
2Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Keisuke Kawamoto, MD1,2*, Jun Takizawa, MD1*, Hiroaki Miyoshi, MD2*, Noriaki Yoshida, MD2*, Yasuhiko Shibasaki, MD3*, Masayoshi Masuko, MD3, Hirohito Sone, MD1*, Naoya Nakamura, MD, Ph.D.4* and Koichi Ohshima, MD, PhD5*

1Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
2Department of Pathology, Kurume University School of Medicine, Kurume, Japan
3Department of Stem Cell Transplantation, Niigata University Medical and Dental Hospital, Niigata, Japan
4Department of Pathology, Tokai University School of Medicine, Isehara, Japan
5Department of Pathology, Kurume University, School of Medicine, Kurume, Japan

Deok-Hwan Yang, MD, PhD1, Joon Ho Moon, M.D., Ph.D.2, Seung-Shin Lee, MD1*, Jung-Joon Min, MD3*, Shin-Young Jeong, MD, PhD4*, Yoo-Jin Lee, MD2*, Sung-Woo Park, MD2*, Yee Soo Chae, M.D.5*, Young Rok Do6, Hyeoung-Joon Kim, MD, PhD1 and Je-Jung Lee7

1Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea
2Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
3Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun, South Korea
4Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, South Korea
5Departments of Hematology/oncology, Kyungpook National University Hospital, Kyungpook, South Korea
6Hematology/Oncology, Dongsan Medical Center, Daegu, South Korea
7Department of Hematology-Oncology,Chonnam National University Hwasun Hospital, Hwasun, South Korea

Rie Nakamoto-Matsubara, MD, PhD1*, Mamiko Sakata-Yanagimoto, MD, Ph.D.1*, Tran Nguyen, MD2*, Junichi Furuta, MD, PhD3*, Takayoshi Ito, MD4*, Takuya Komeno5, Seishi Ogawa, MD, PhD6* and Shigeru Chiba, M.D., Ph.D.1

1Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
2Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
3Department of dermatology, University of Tsukuba, Tsukuba, Japan
4Department of hematology, JA Toride Medical Center, Toride, Japan
5Department of Hematology, National Hospital Organization, Mito Medical Center, Mito, Japan
6Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Nerea Martinez1*, Carmen Almaraz1*, Manuela Mollejo2*, Yolanda Campos-Martin2*, Sophia Derdak3*, Laura Cereceda1*, Alexandra Traverse-Glehen4*, Aurelie Verney4*, Lucile Baseggio5*, Fanny Camacho6*, Jose Pedro Vaque1*, Sergi Beltran3*, Ivo Gut3* and Miguel Angel A. Piris7

1Cancer Genomics, IDIVAL, Santander, Spain
2Department of Genetics and Pathology, H. Virgen de la Salud, Toledo, Spain
3CNAG, Barcelona, Spain
4Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon 1, Lyon, France
5Hematology laboratory, Hospices Civils de Lyon, France, Lyon, France
6Department of Pathology, Hospital U. Getafe, Getafe, Spain
7Department of Pathology, Hospital Marques de Valdecilla, Santander, Spain

Nicola J Camp, PhD1,2*, Rosalie G Waller, BS1,3, Cassandra Garner, BS4, Guido J Tricot, MD, PhD5, Michael Tomasson, MD6, Djordje Atanackovic, MD1,2 and Martha Glenn, MD1

1Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, UT
2Huntsman Cancer Institute, Salt Lake City, UT
3Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT
4Human Genetics, University of Utah, Salt Lake City, UT
5Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
6Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO

Neta Goldschmidt, MD,1*, Fares Darawshy2*, Elena Slyusarevsky2*, Galina Pogrebijski2*, Dina Ben Yehuda3* and Moshe E. Gatt, MD4

1Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2Hadassah-Hebrew University Medical Center, Jerusalem, Israel
3Hematology Division, Hadassah Medical Center, Jerusalem, Israel
4Hadassah Hebrew University Medical Center, Jerusalem, Israel

Chao Wang, MD1,2,3, Qiang Gong, PhD1*, Weiwei Zhang2*, Javeed Iqbal, PhD2*, Yang Hu2*, Timothy C. Greiner, MD2, Adam Cornish2*, Raul Rabadan, PhD4*, Francesco Abate, PhD4*, Xin Wang, MD, PhD5, Giorgio Inghirami, MD6*, McKeithan W. Timothy, MD, PhD1* and Wing C Chan, MD1*

1Department of Pathology, City of Hope Medical Center, Duarte, CA
2Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
3Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
4Department of Biomedical Informatics, Columbia University, New York, NY
5Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
6Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY

Anne-Ségolène Cottereau, MD1*, Hélène Lanic, MD1*, Michel Meignan, MD, PhD2*, Pierre Vera, MD, PhD1*, Hervé Tilly, MD, PhD3, Fabrice Jardin, MD, PhD4* and Stéphanie Becker, MD, PhD1*

1Centre Henri Becquerel, Rouen, France
2Nuclear Medicine Department, Hôpital Henri Mondor, Créteil, France
3INSERM U918, Centre Henri Becquerel, Rouen, France
4Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France

Andrew G. Evans, MD, PhD*, Janice M. Spence, PhD*, Stephen A. Spence*, Paul G. Rothberg, PhD and Richard Burack, MD, PhD,

Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY

Xiaoxiao Hao*, Yongqiang Wei*, Fen Huang*, Xiaolei Wei, Dr.*, Yuankun Zhang* and Ru Feng

Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Linn Rønlev Reinholdt, PhD Student1*, Maria Bach Laursen, PhD1*, Steffen Falgreen, PhD1*, Alexander Schmitz, Dr. rer. nat.2*, Julie Støve Bødker, PhD1*, Martin Boegsted, Professor MSO1,3*, Hans Erik Johnsen, Professor, MD1,4 and Karen Dybkaer, Professor MSO1,3*

1Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
2Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
3Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
4Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Gita Thanarajasingam, MD1*, Matthew J Maurer, MS2, Umar Farooq, MD3, Patrick B. Johnston, MD, PhD1*, Carrie Thompson, MD1, Stephen Ansell, MD, PhD4, Luis Porrata, MD4, William Macon, MD4*, Sergei Syrbu, MD5*, James Cerhan, MD, PhD2, Thomas M. Habermann, MD1, Thomas E. Witzig, MD1, Brian K Link, MD3 and Grzegorz S. Nowakowski, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Health Sciences Research, Mayo Clinic, Rochester, MN
3Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
4Mayo Clinic, Rochester, MN
5University of Iowa, Iowa City, IA

Soo-Jeong Kim, M.D.1*, Hyunsung Park, M.D1*, Hyunsoo Cho, M.D.2*, Yu Ri Kim, M.D., Ph.D.1, Jung Yeon Lee, M.D.2*, Ji Eun Jang, M.D.2*, Kim Yundeok, M.D.2*, June-Won Cheong, M.D., Ph.D.2, Yoo Hong Min, M.D., Ph.D.2 and Jin Seok Kim, M.D., Ph.D.2*

1Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
2Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea

He Huang*, Jiatian Lin*, Chengcheng Guo*, Shanshan Li, MD*, Huangming Hong*, Xueying Li*, Mengping Zhang*, Zhongjun Xia, MD and Tongyu Lin*

Sun Yat-sen University Cancer Center, Guangzhou, China

Cordula Tschuch, PhD1*, Kerstin Klingner1*, Dorothee Lenhard1*, Cyrill Rentsch, MD, PhD2*, Christian Wetterauer2*, Lukas Bubendorf, MD2*, Tatjana Vlajndic, MD2*, Milena Pantic, PhD3*, Lisa K Isbell, MD3*, Nikolas von Bubnoff, MD3*, Teppo Haapaniemi, PhD4* and Julia B. Schueler, DVM, PhD1

1Oncotest GmbH, Freiburg, Germany
2University Hospital Basel, Basel, Switzerland
3Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
4BioSiteHisto Oy, Tampere, Finland

Uma Borate, MD1, Deniz Peker, MD2*, James M. Foran, MD3 and Luciano J Costa, MD, PhD4

1Univ. of Alabama at Birmingham, Birmingham, AL
2Pathology, University of Alabama-Birmingham, Birmingham, AL
3Mayo Clinic Cancer Center, Jacksonville, FL
4Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Jae-Cheol Jo, MD, PhD1*, Yunsuk Choi, MD, PhD1*, Hee Jeong Cha2*, Eun Hee Lee3*, Eun Kyoung Kang3* and Hawk Kim, MD, PhD4

1Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea
2Pathology, Ulsan University Hospital, Ulsan, South Korea
3Ulsan University Hospital, Hematology and Oncology, Ulsan, South Korea
4Ulsan University Hospital, Department of Hematology and Oncology, Associate Professor, Ulsan, South Korea

Chun Chao, PhD1, Patricia A Young, MD2*, Lanfang Xu, PhD1*, Michael J. Silverberg, PhD, MPH3*, Jonathan W. Said, MD4* and John M. Timmerman, MD2

1Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA
2Division of Hematology & Oncology, University of California, Los Angeles, Los Angeles, CA
3Division of Research, Kaiser Permanente Northern California, Oakland, CA
4Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA

Yotaro Ochi, M.D.1*, Yusuke Koba, M.D.1*, Yoshimitsu Shimomura, M.D.1*, Yuichiro Ono, M.D.1*, Nobuhiro Hiramoto, M.D.2*, Satoshi Yoshioka, M.D., Ph.D.1, Sumie Tabata, M.D., Ph.D.1*, Noboru Yonetani, M.D.1*, Akiko Matsushita, M.D.1*, Hisako Hashimoto, M.D., Ph.D.2*, Yukihiro Imai, M.D., Ph.D.3* and Takayuki Ishikawa, M.D., Ph.D.1

1Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
2Department of Cell Therapy, Foundation for Biomedical Research and Innovation, Kobe, Japan
3Department of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe, Japan

Marine Armand1*, Myriam Boudjoghra1*, Aliki Xochelli2*, Danielle Canioni3, Magali Le Garff Tavernier1*, Monica Colombo, PhD4*, Pascaline Rabiega5*, Thierry Molina3*, Frederic Charlotte6*, Jean-Marie Michot7*, Claude Lesty1*, Fabrice Carrat5*, Manlio Ferrarini, MD8*, Kostas Stamatopoulos2,9*, Caroline Besson10, Olivier Hermine11* and Frederic Davi1*

1Department of Hematology, Pitié-Salpêtrière Hospital and Pierre et Marie Curie University, Paris, France
2Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
3Department of Pathology, Paris 5 Descartes University, AP-HP, Hopital Necker, Paris, France
4Direzione Scientifica, IRCCS San Martino-IST, Genoa, Italy
5Institut Pierre Louis d’Epidémiologie et de Santé Publique INSERM UMR S1136, Pierre et Marie Curie University, Paris, France
6Department of Pathology, Pitié-Salpêtrière Hospital and Pierre et Marie Curie University, Paris, France, Paris, France
7Department of Hematology and Drug Developmen, Gustave Roussy Institute, Villejuif, France
8Direzione Scientifica, IRCCS SanMartino-IST, Genoa, Italy
9Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
10Department of Internal Medicine & Clinical Immunology Biological Immunology and Hematolog, Bicetre Hospital and Paris Sud University, Le Kremlin Bicêtre, France
11Department of Adult Hematology, Hopital Necker and Paris Descartes University, Paris, France

Luigi Marcheselli1*, Alessia Bari2*, Raffaella Marcheselli1*, Tamar Tadmor3*, Samantha Pozzi4*, Maria Christina Cox, MD PhD5, Luca Baldini6*, Angela Ferrari7*, Paola Ferri1*, Massimo Federico8, Aaron Polliack9 and Stefano Sacchi10

1Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
2Program of Innovative Therapy in Oncology and Hematology, Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
3Hematology-Oncology Unit, Bnai Zion Medical Center, Haifa, Israel; Rappaport Faculty of Medicine, Technion, Haifa, Israel
4Program of Innovative Therapies in Oncology and Haematology, Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
5Hematology, Azienda Ospedaliera S. Andrea, Rome, Italy
6Division of Hematology, Fondazione IRCCS Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy
7Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
8Department of Diagnostic and Clinical Medicine, and Public Health, University of Modena and Reggio Emilia, Modena, Italy
9Department of Hematology, Hadassah University Hospital, Jerusalem, Israel
10Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy

Mayra R Montecillo-Aguado, MsC1*, Gabriel G Vega, PhD student2*, Hector Mayani, PhD3, Sara Huerta-Yepez, PhD4*, Benjamin Bonavida, Ph.D.5, Otoniel Martinez-Maza, PhD6* and Mario I. Vega, PhD6,7

1CMN Siglo XXI IMSS, Mexico City, Mexico
21Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center IMSS, Mexico DF, Mexico
3Oncology Reserach Unit, Siglo XXI National Medical Center IMSS, Mexico, Mexico
4Unidad de Investigacion en Enfermedades Oncologicas, Hospital Infantil de Mexico Federico Gomez SSA, Mexico City, Mexico
5Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
6Department of Gynecology & Obstetric, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
7Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center IMSS, Mexico D.F., Mexico

Tianjiao Wang, Ph.D.1, Ye Lu, MD2*, Avery Polk2*, Carlos Murga Zamalloa, MD3* and Ryan A Wilcox, MD, PhD1

1Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI
2Cancer Center, University of Michigan, Ann Arbor, MI
3Pathology, University of Michigan, Ann Arbor, MI

Gabriel G Vega, PhD student1*, Luz A Franco-Cea2*, Sara Huerta-Yepez, PhD3*, Hector Mayani, PhD4, Otoniel Martinez-Maza, PhD5*, Benjamin Bonavida, Ph.D6 and Mario I. Vega, PhD7

11Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center IMSS, Mexico DF, Mexico
2Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico
3Unidad de Investigacion en Enfermedades Oncologicas, Hospital Infantil de Mexico Federico Gomez SSA, Mexico City, Mexico
4Oncology Reserach Unit, Siglo XXI National Medical Center IMSS, Mexico, Mexico
5Department of Gynecology & Obstetric, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
6Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA
7Department of Gynecology & Obstetrics, David Geffen School of Medicine UCLA, University of California Los Angeles, Los Angeles, CA

Richard Dillon, MA, MRCP, FRCPath1,2*, Lucy Cook3,4*, Alka Saxena5*, Rosamond Nuamah5*, Ghazala Mirza5*, Amie Jaye6*, Michael Simpson6*, Sean Whittaker7*, Charles R. M. Bangham8*, Graham P. Taylor3,4* and Paul Fields, MD PhD1

1Department of Haematology, Guy's and St Thomas' Hospitals NHS Trust, London, United Kingdom
2Medical and Molecular Genetics, King's College, London, London, United Kingdom
3Imperial College Healthcare NHS Trust, London, United Kingdom
4Imperial College, London, London, United Kingdom
5Guy's and St Thomas' Hospitals NHS Trust, Genomics Core Facility, NIHR Biomedical Research Centre, London, United Kingdom
6Medical and Molecular Genetics, King's College London, London, United Kingdom
7Kings College London, St John's Institute of Dermatology, London, England
8Imperial College London, London, United Kingdom

Julia Friedman, Ph.D.1*, Asha Guttapalli, M.Sc.1*, Charles Ma, Ph.D.1*, Venkata Thodima, Ph.D.1*, Raghavendra Padmanabhan1*, Sitharthan Kamalakaran, Ph.D.1*, Imran N Siddiqi, M.D, Ph.D.2* and Jane Houldsworth, Ph.D.1

1Cancer Genetics, Inc., Rutherford, NJ
2Hematopathology Section, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA

Kitsada Wudhikarn, MD1*, Udomsak Bunworasate, MD2*, Arnuparp Lekhakula, MD, MS3*, Jakrawadee Julamanee, MD3*, Chittima Sirijerachai, MD4*, Kanchana Chansung, MD4*, Lalita Norasetthada, MD5, Weerasak Nawarawong, MD6, Archrob Khuhapinant, MD, PhD7, Supachai Ekwattanakit, MD, PhD7*, Tontanai Numbenjapon, MD8*, Kannadit Prayongratana, MD9*, Suporn Chuncharunee, MD10, Pimjai Niparuck, MD10*, Tawatchai Suwanban, MD11*, Nonglak Kanitsap, MD12*, Somchai Wongkhantee, MD13*, Rachanid Pornvipavee, MD14*, Peerapon Wong, MD15*, Nisa Makruasi, MD16*, Pannee Praditsuktavorn, MD17* and Tanin Intragumtornchai, MD, MSc1

1Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
2Department of Medicine, Chulalongkorn University, Bangkok, Thailand
3Department of Internal Medicine, Prince of Songkla University, Songkla, Thailand
4Department of Medicine, Khon Kaen University, Khon Kaen, Thailand
5Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand
6Department of Medicine, Chiang Mai University, Chiang Mai, Thailand
7Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
8Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
9Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
10Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
11Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
12Department of Medicine, Thammasat University, Bangkok, Thailand
13Department of Medicine, Khonkaen Regional Hospital, Khon Kaen, Thailand
14Department of Internal Medicine, Navamindradhiraj University, Bangkok, Thailand
15Department of Medicine, Naresuan University, Phitsanulok, Thailand
16Department of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand
17Department of Internal Medicine, Chulabhorn Hospital, Bangkok, Thailand

Sydney Dubois1,2,3*, Bruno Tesson4*, Pierre-Julien Viailly1,2,3,5*, Thierry Molina6*, Christiane Copie-Bergman7*, Sylvain Mareschal1,2,3*, Elodie Bohers, PhD1,2,3*, Philippe Bertrand, PhD1,2,3*, Philippe Ruminy, PhD1,2,3*, Catherine Maingonnat1,2,3*, Jean-Philippe Jais4*, Pauline Peyrouze8*, Martin Figeac, PhD8*, Fabienne Desmots9*, Thierry Fest9*, Corinne Haioun, MD, PhD10, Thierry Lamy, MD, PhD11, Josette Briere12,13*, Tony Petrella14*, Danielle Canioni, MD15, Bettina Fabiani16*, Bertrand Coiffier17*, Richard Delarue, MD18, Frederic Peyrade, MD19*, André Bosly, MD, PhD20, Marc Andre, MD20*, Nicolas Ketterer21, Gilles A. Salles, MD, PhD22, Hervé Tilly, MD, PhD1,2,3,23, Karen Leroy, MD, PhD24* and Fabrice Jardin1,2,3,23*

1Université de Rouen, Rouen, France
2INSERM U918, Centre Henri Becquerel, Rouen, France
3IRIB, Rouen, France
4INSERM UMRS 872, AP-HP Hôpital Necker, Paris, France
5LITIS EA 4108, Rouen, France
6Department of Pathology, Hôpital Necker, Paris, France
7IMRB – Inserm U955, AP-HP Hôpital Henri Mondor, Créteil, France
8Université de Lille 2, Lille, France
9INSERM U917, CHU Pontchaillou, Rennes, France
10Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France
11Haematology, CHU Pontchaillou, Rennes, France
12Hôpital Saint-Louis, Paris, France
13INSERM U728, Université Paris Diderot, Paris, France
14Department of Pathology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
15Hopital Necker, Paris, France
16AP-HP Hôpital Saint Antoine, Paris, France
17CNRS UMR5239, Hospices Civils de Lyon, Pierre-Benite, France
18Hematology Department, AP-HP Hôpital Necker, Paris, France
19Department of Hematology, Centre Antoine Lacassagne, Nice, France
20Hematology Department, CHU Dinant Godinne, Yvoir, Belgium
21Department of Oncology, Lausanne Hospital, Lausanne, Switzerland
22Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
23Department of Hematology, Centre Henri Becquerel, Rouen, France
24INSERM U955, AP-HP Hôpital Henri Mondor, Creteil, France

Jin-Hua Liang1*, Jin Sun2*, Li Wang1*, Lei Fan, MD., PhD.1*, Li Tian-Nv2*, Jian-Yong Li, MD, PhD1 and Wei Xu1*

1Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
2Department of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Benedetta Apollonio, PhD1*, Nicole S. Nicholas, PhD1*, Lesley-Ann Sutton2*, Jon Salisbury3*, Piers E. Patten, BSc, MRCP, MRCPath, PhD4, Shireen Kassam, FRCPath, MD, MBBS, PhD3*, Stephen Devereux, FRCP, FRCPath, PhD4, Rose Marie Amini, PhD2*, Richard Rosenquist2 and Alan G. Ramsay, PhD1

1Department of Haemato-Oncology, King’s College London, London, United Kingdom
2Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
3King's College Hospital, London, United Kingdom
4Haematology, King's College Hospital, London, United Kingdom

Elizabeth Michelle Margolskee, MD1*, Vaidehi Jobanputra1*, Preti Jain1*, Jinli Chen1*, Odelia Nahum1*, Brynn Levy1*, Karthik A Ganapathi, MD, PhD1*, Vundavalli Murty1*, Thomas Tousseyn, MD PhD2*, Bachir Alobeid, MD1*, Mahesh Manuskhani, MD1* and Govind Bhagat, MD, MBBS1

1NYP-Columbia University Medical Center, New York, NY
2Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium

Bartlomiej Getta, MBBS,1*, Kaitlin M Woo, MS2*, Sean Devlin, PhD2*, Jae H. Park, MD3, Omar Abdel-Wahab1 and Martin S Tallman, MD4

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Michael P. Chu, MD1, Andrew Belch, MD1, Lixia Pei, PhD2*, Xue (Loya) Yang, PhD3*, Tadeusz Robak, MD, PhD4, Brendan Rooney, PhD5*, Andrew Cakana, MD6, Helgi van de Velde, MD, PhD7* and Michael B Sawyer, MD1*

1Cross Cancer Institute, Edmonton, AB, Canada
2Research and Development, Janssen Research and Development, Raritan, NJ
3Biostatistics, Janssen Research and Development, Shanghai, China
4Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
5Janssen Research & Development, High Wycombe, United Kingdom
6Research and Development, Janssen Pharmaceuticals, Harare, Zimbabwe
7Millennium Pharmaceuticals, Inc., Cambridge, MA

Imane Azzaoui, PhD1*, Fabrice Uhel, MD1*, Delphine Rossille, PhD2*, Céline Pangault, PharmD PhD3*, Joelle Dulong3*, Jerome Le Priol, PhD1*, Thierry Lamy, MD PhD3, Roch Houot, MD, PhD3*, Steven Le Gouill, MD, PhD4*, Guillaume Cartron, MD, PhD5*, Pascal Godmer, MD6*, Krimo Bouabdallah, MD7*, Noel Milpied, MD, PhD7, Karin Tarte, PhD3*, Thierry Fest, MD, PhD3* and Mikael Roussel, MD, PhD3*

1CHU de Rennes, Rennes, France
2CHU Rennes, Rennes, France
3INSERM U917 - CHU de Rennes, Rennes, France
4CHU de Nantes, INSERM UMR 892 équipe 10, Nantes, France
5CHU de Montpellier, Montpellier, France
6CH de Vannes, Vannes, France
7CHU de Bordeaux, Bordeaux, France

Aliki Xochelli1,2*, Vasilis Bikos3*, Eleftheria Polychronidou4,5*, Andreas Agathangelidis6*, Frederic Charlotte7*, Panagiotis Moschonas4*, Zadie Davis8*, Monica Colombo, PhD9*, Maria Roumelioti10*, Lesley-Ann Sutton11*, Patricia Groenen12*, Myriam Boudjoghra13*, Patricia Algara14*, Alexandra Traverse-Glehen15*, Ana Ferrer16*, Evangelia Stalika2*, Maria Karypidou17*, George Kanellis18*, Christina Kalpadakis, MD, PhD19*, Manuella Mollejo14*, Gerasimos Pangalis20*, Panayiotis Vlamos5*, Rose-Marie Amini11*, Sarka Pospisilova3*, David Gonzalez21*, Maurilio Ponzoni22*, Achilles Anagnostopoulos17, Veronique Giudicelli23*, Marie-Paule Lefranc23*, Blanca Espinet16*, Panagiotis Panagiotidis10*, Miguel Angel Piris24*, Ming Du25*, Richard Rosenquist11, Theodora Papadaki18*, Chrysoula Belessi26, Manlio Ferrarini, MD27*, David Oscier8, Dimitrios Tzovaras4*, Paolo Ghia6*, Frederic Davi28*, Anastasia Hadzidimitriou2* and Kostas Stamatopoulos2,11*

1Center for Research and Technology Hellas, Thessaloniki, Greece
2Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
3Central European Institute of Technology, Masaryk University, Brno, Czech Republic
4Information Technologies Institute, CERTH, Thessaloniki, Greece
5Department of Informatics, Ionian University, Corfu, Greece
6Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
7Department of Pathology, Hopital Pitie-Salpetriere and Universite Pierre Curie, Paris, France
8Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
9Direzione Scientifica, IRCCS San Martino-IST, Genoa, Italy
10First Department of Propaedeutic Medicine, University of Athens, Athens, Greece
11Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
12Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands
13Department of Hematology, Pitié-Salpêtrière Hospital and Pierre et Marie Curie University, Paris, France
14Hospital Virgen de la Salud, Toledo, Spain
15Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon 1, Lyon, France
16Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain
17Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
18Hematopathology Department, Evangelismos Hospital, Athens, Greece
19Department of Hematology, University of Crete, School of Medicine, Heraklion, Greece
20Department of Haematology, Athens Medical Center, Athens, Greece
21Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom
22Pathology Unit, San Raffaele Scientific Institute, Milan, Italy
23IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France
24Hospital Universitario Marques de Valdecilla, Santander, Spain
25Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
26Hematology Department, Nikea General Hospital, Piraeus, Greece
27Direzione Scientifica, IRCCS SanMartino-IST, Genoa, Italy
28Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France

Yuichiro Ono, M.D.1*, Daisuke Kato, M.D.1*, Tomohiro Yabushita, M.D.1*, Yoshimitsu Shimomura, M.D.1*, Yusuke Koba, M.D.1,2*, Yotaro Ochi, M.D.1*, Nobuhiro Hiramoto, M.D.2*, Satoshi Yoshioka, M.D., Ph.D.1*, Sumie Tabata, M.D., Ph.D.1*, Noboru Yonetani, M.D.1*, Akiko Matsushita, M.D.1*, Yukihiro Imai, M.D., Ph.D.3*, Hayato Maruoka, M.T4*, Hisako Hashimoto, M.D., Ph.D.2* and Takayuki Ishikawa, M.D., Ph.D.1

1Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
2Department of Cell Therapy, Foundation for Biomedical Research and Innovation, Kobe, Japan
3Department of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe, Japan
4Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan

James Storhoff1*, Brett Wallden1*, Rita M. Braziel2, Catherine Thieblemont3, Tressa Hood1*, Harini Ravi1*, Shannon Dennis1*, Naeem Dowidar1*, Patrick Danaher1*, Jennifer Dunlap, MD4, Josette Briere3*, Eric de Kerviler3* and Sean Ferree1*

1NanoString Technologies, Inc., Seattle, WA
2Oregon Health & Science University, Portland, OR
3Hôpital Saint-Louis, Paris, France
4Department of Pathology, Oregon Health & Science University, Portland, OR

Yvonne Akotoa Dei-Adomakoh, MBBS1*, Eugenia Quartey, MBChB2*, Catherine Idara Segbefia, MBChB3*, Elsie Amedonu, BSc1*, Afua Abrahams, MBChB1* and Joseph Acquaye, MBBS1*

1University of Ghana, School of Biomedical and Allied Health Sciences, Accra, Ghana
2Korle Bu Teaching Hospital,Accra,Ghana, Accra, Ghana
3University of Ghana, School of Medicine and Dentistry, Accra, Ghana

Arjun Gupta, MD1* and Harris V. Naina, MD2

1University of Texas Southwestern Medical Center, Dallas, TX
2Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX

Anamarija M. Perry, MD1, Diebold Jacques, MD2*, Bharat N. Nathwani, M.D.3, Kenneth Angus Maclennan, MD4*, H Konrad Müller-Hermelink5*, Eugene Boilesen6*, Martin Bast, BS6*, James O. Armitage, MD7 and Dennis D. Weisenburger, MD8

1University of Manitoba, Winnipeg, MB, Canada
2Hotel-Dieu, University Denis Diderot, Paris, France
3Department of Pathology, City of Hope Medical Center, Duarte, CA
4Leeds Institute of Molecular Medicine, Leeds, United Kingdom
5University of Würzburg, Würzburg, Germany
6University of Nebraska Medical Center, Omaha, NE
7Department of Internal Medicine, Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
8City of Hope National Medical Center, Duarte, CA

Kimon V. Argyropoulos, MD1*, Steven M Horwitz, MD2, Franck Rapaport, PhD3*, Enrico Velardi, PhD4*, Patricia Myskowski, MD5*, Christiane Querfeld6*, Melissa Pulitzer, MD7*, Ahmet Dogan, MD, PhD7, Meighan Gallagher, MA8*, Nicholas D. Socci, PhD3*, Ross L. Levine, MD9, Minal Patel, BA10*, Natasha Galasso5*, Marcel van den Brink, MD, PhD11 and Lia Palomba, MD5

1Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY
4Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Dermatology, City of Hope, Duarte, CA
7Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
8Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
9Memorial Sloan Kettering Cancer Center, New York, NY
10Hematologic Oncology Tissue Bank, Memorial Sloan Kettering Cancer Center, New York
11Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Lian Xu1*, Zachary Hunter, PhD1*, Nicholas Tsakmaklis1*, Yang Cao, MD1,2*, Guang Yang, PhD1, Jie Chen, PhD1*, Xia Liu, MD1*, Sandra Kanan, NP, RN, MSN1*, Jorge J Castillo, MD1, Yu-Tzu Tai, PhD3, James L. Zehnder, MD4, Jennifer R. Brown, MD, PhD5, Ruben D. Carrasco, MD, PhD5, Ranjana H Advani, MD6, Kimon V. Argyropoulos, MD7*, M. Lia Palomba, MD8, Enrica Morra, MD9, Alessandra Trojani, PhD9*, Antonino Greco, MD9*, Alessandra Tedeschi, MD9*, Marzia Varettoni, MD10*, Luca Arcaini11*, Nikhil C. Munshi, MD3, Kenneth C Anderson, MD3 and Steven P Treon, MD, PhD1

1Bing Center for WM, Dana Farber Cancer Institute, Boston, MA
2Dept of Physiology & Biophysics, University of California, Irvine, Irvine, CA
3Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA
4Department of Pathology, School of Medicine, Stanford University, Stanford, CA
5Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
6School of Medicine, Dept of Medical Oncology, Stanford University Medical Center, Stanford, CA
7Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Division of Hematology, Niguarda Cà Granda Hospital, Milan, Italy
10Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
11Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Iris Wieser, MD1*, Chee Won Oh, MD, PhD2*, Rakhshandra Talpur, MD1* and Madeleine Duvic, MD1

1Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX

Wang Casey, MD1*, Rakhshandra Talpur, MD2*, Silvia Alberti-Violetti, MD3*, Iris Wieser, MD2*, Casey Tran4* and Madeleine Duvic, MD5

1Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Universoty of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas MD Anderson Cancer Center, Houston, TX
5Dept. of Dermatology, M.D. Anderson Cancer Center, Houston, TX

Hyunsung Park, M.D1*, Hyunsoo Cho, M.D.2*, Jungyeon Lee, M.D.2*, Jieun Jang, MD2*, Yundeok Kim, MD2*, Soo Jeong Kim, M.D.2*, Yu Ri Kim, M.D., Ph.D.1, June-Won Cheong, M.D., Ph.D.2, Yoo Hong Min, M.D., Ph.D.2 and Jin Seok Kim, M.D., Ph.D.2*

1Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
2Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea

Genevieve Marie Crane, MD, PhD1*, Helen Powell, PhD2*, Rumen Kostadinov, PhD3*, Peter C. Burger, MD4*, Richard F. Ambinder, MD, PhD5, Lode J. Swinnen, MBChB6, Michael J. Borowitz, MD, PhD7 and Amy S. Duffield, MD, PhD8

1Johns Hopkins School of Medicine, Baltimore, MD
2Department of Biostatistics, The Johns Hopkins Bloomberg School of Public Health, Baltimore
3Department of Biostatistics, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
4Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore
5Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins Medical Institutions, Baltimore, MD
6Medical Oncology, Johns Hopkins, Baltimore, MD
7Hematologic Pathology, Johns Hopkins University, Baltimore, MD
8Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD

*signifies non-member of ASH